PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(-1.55%)
IDR 635.0
(-1.55%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1257.75 Billion IDR | -6.02% |
| 2022 | 1338.39 Billion IDR | -14.72% |
| 2021 | 1569.35 Billion IDR | 16.57% |
| 2020 | 1346.31 Billion IDR | 35.98% |
| 2019 | 990.05 Billion IDR | 14.11% |
| 2018 | 867.63 Billion IDR | 7.95% |
| 2017 | 803.73 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 355.03 Billion IDR | -11.25% |
| 2024 Q1 | 400.02 Billion IDR | 22.88% |
| 2024 Q3 | 378.69 Billion IDR | 9.29% |
| 2023 Q2 | 317.78 Billion IDR | 1.7% |
| 2023 FY | 1257.75 Billion IDR | -6.02% |
| 2023 Q4 | 325.54 Billion IDR | -3.74% |
| 2023 Q3 | 338.19 Billion IDR | 6.42% |
| 2023 Q1 | 312.48 Billion IDR | 1.0% |
| 2022 Q4 | 309.37 Billion IDR | -11.11% |
| 2022 Q3 | 348.02 Billion IDR | 24.42% |
| 2022 Q2 | 279.72 Billion IDR | -30.29% |
| 2022 Q1 | 401.27 Billion IDR | 51.45% |
| 2022 FY | 1338.39 Billion IDR | -14.72% |
| 2021 Q2 | 386.89 Billion IDR | 2.22% |
| 2021 Q3 | 539.01 Billion IDR | 39.32% |
| 2021 Q1 | 378.49 Billion IDR | 17.53% |
| 2021 FY | 1569.35 Billion IDR | 16.57% |
| 2021 Q4 | 264.95 Billion IDR | -50.84% |
| 2020 Q2 | 342.17 Billion IDR | -14.62% |
| 2020 Q4 | 322.02 Billion IDR | 21.99% |
| 2020 Q3 | 263.97 Billion IDR | -22.85% |
| 2020 Q1 | 400.75 Billion IDR | 69.41% |
| 2020 FY | 1346.31 Billion IDR | 35.98% |
| 2019 Q4 | 236.55 Billion IDR | 0.0% |
| 2019 Q1 | 259.63 Billion IDR | 0.0% |
| 2019 FY | 990.05 Billion IDR | 14.11% |
| 2018 FY | 867.63 Billion IDR | 7.95% |
| 2017 FY | 803.73 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 2913.35 Billion IDR | 56.828% |
| PT Itama Ranoraya Tbk | 127.06 Billion IDR | -889.884% |
| PT Kimia Farma (Persero) Tbk | 2780.27 Billion IDR | 54.762% |
| PT Millennium Pharmacon International Tbk | 273.37 Billion IDR | -360.083% |